Prognostic impact of residual HPV ctDNA detection after chemoradiotherapy for anal canal carcinoma.

被引：1
|
作者：
Cabel, Luc
Jeannot, Emmanuelle
Bieche, Ivan
Vacher, Sophie
Callens, Celine
Bernard, Alice
Morel, Adeline
Lievre, Astrid
Otz, Joelle
Minsat, Mathieu
Bazire, Louis
Pierga, Jean-Yves
Buecher, Bruno
Mariani, Pascale
Bidard, Francois Clement
Cacheux, Wulfran
机构：
[1] Inst Curie, Paris, France
[2] Inst Curie Hop, Paris, France
[3] CHU Pontchaillou, Rennes, France
[4] Inst Curie, St Cloud, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.3565
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3565
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Intracavitary afterloading boost in anal canal carcinoma. Results, function and quality of life
    Vordermark D.
    Flentje M.
    Sailer M.
    Kölbl O.
    [J]. coloproctology, 2002, 24 (1) : 14 - 21
  • [22] Systemic therapy for advanced anal canal carcinoma. Case report and a review of the literature
    Serkies, Krystyna
    Romanowska, Anna
    Jassem, Jacek
    [J]. ONCOLOGY IN CLINICAL PRACTICE, 2013, 9 (06): : 245 - 249
  • [23] HPV ctDNA detection of high-risk HPV types during chemoradiotherapy for locally advanced cervical cancer
    Cabel, L.
    Bonneau, C.
    Bernard-Tessier, A.
    Hequet, D.
    Tran-Perennou, C.
    Bataillon, G.
    Rouzier, R.
    Feron, J-G
    Fourchotte, V
    Le Brun, J-F
    Benoit, C.
    Rodrigues, M.
    Scher, N.
    Minsat, M.
    Legrier, M-E
    Bieche, I
    Proudhon, C.
    Sastre-Garau, X.
    Bidard, F-C
    Jeannot, E.
    [J]. ESMO OPEN, 2021, 6 (03)
  • [24] Treatment outcomes and prognostic factors after chemoradiotherapy for anal cancer
    Slordahl, Kathinka S.
    Klotz, Dagmar
    Olsen, Jan-Age
    Skovlund, Eva
    Undseth, Christine
    Abildgaard, Heidi Larsen
    Braendengen, Morten
    Nesbakken, Arild
    Larsen, Stein Gunnar
    Hanekamp, Bettina A.
    Holmboe, Laila
    Tvedt, Ragnhild
    Sveen, Anita
    Lothe, Ragnhild A.
    Malinen, Eirik
    Kaasa, Stein
    Guren, Marianne Gronlie
    [J]. ACTA ONCOLOGICA, 2021, 60 (07) : 921 - 930
  • [25] Treatment outcome and prognostic factors after chemoradiotherapy for anal cancer
    Slordahl, K. S.
    Olsen, J-A.
    Klotz, D.
    Skovlund, E.
    Undseth, C.
    Abildgaard, H. L.
    Braendengen, M.
    Nesbakken, A.
    Larsen, S. G.
    Hanekamp, B.
    Holmboe, L.
    Tvedt, R.
    Malinen, E.
    Kaasa, S.
    Guren, M. G.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S458 - S459
  • [26] Clinical impact of tomoEDGE in the treatment of anal canal carcinoma
    Pellanda, A. Franzetti
    Corradini, N.
    Negretti, L.
    Schombourg, K.
    Biggiogero, M.
    Leick, M.
    Ballerini, G.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S72 - S72
  • [27] STUDY OF IMPACT ON THE QUALITY OF LIFE AFTER RADIOCHEMOTHERAPY OF LOCALLY ADVANCED ANAL CANAL CARCINOMA
    Kumbhaj, D. P.
    Sharma, D. R.
    [J]. ANNALS OF ONCOLOGY, 2013, 24
  • [28] Postradiation ctDNA status as a prognostic factor in locally advanced esophageal squamous cell carcinoma.
    Jia, Ru
    Li, Pansong
    Zhao, Chuanhua
    Wang, Yan
    Liu, Rongrui
    Chang, Lianpeng
    Guan, Yanfang
    Yi, Xin
    Xu, Jian-Ming
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [29] Prognostic factors after hepatectomy for hepatocellular carcinoma.
    Lau, H
    Fan, ST
    Ng, I
    Wong, J
    [J]. GASTROENTEROLOGY, 1998, 114 (04) : A1404 - A1404
  • [30] Salvage surgery for residual primary anal squamous cell carcinoma after chemoradiotherapy in HIV-positive individuals
    Alfa-Wali, M.
    Safarfashandi, L.
    Ion, L.
    Nelson, M.
    Allen-Mersh, T.
    Bower, M.
    [J]. HIV MEDICINE, 2013, 14 : 28 - 28
12345